Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Arterioscler Thromb Vasc Biol Retrieve available abstracts of 63 articles: HTML format

Single Articles

October 2025
1. POLKINGHORNE MD, Badi I, Baragetti A, Chauhan J, et al
   Lipoprotein(a) and Vascular Redox State in Patients With Advanced Coronary Atherosclerosis.
   Arterioscler Thromb Vasc Biol. 2025 Oct 30. doi: 10.1161/ATVBAHA.125.322924.
   PubMed     Abstract available
   
   
   
2. ABOHASHEM S, Saeed F, Munzel T, Al Kindi S, et al
   Imaging Findings Associated With Socioenvironmental Exposures Inform Mechanisms of Cardiovascular Disease.
   Arterioscler Thromb Vasc Biol. 2025 Oct 9. doi: 10.1161/ATVBAHA.125.322470.
   PubMed     Abstract available
   
   
   
3. CHO DI, Ahn JH, Kang BG, Hwang I, et al
   ANGPTL4 Prevents Atherosclerosis by Preserving KLF2 to Suppress EndMT and Mitigates Endothelial Dysfunction.
   Arterioscler Thromb Vasc Biol. 2025;45:1742-1761.
   PubMed     Abstract available
   
   
   September 2025
4. REIJNDERS E, Bossuyt P, Jukema JW, Ruhaak LR, et al
   Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy.
   Arterioscler Thromb Vasc Biol. 2025 Sep 25. doi: 10.1161/ATVBAHA.124.322336.
   PubMed     Abstract available
   
   
   
5. GERDTS E, Novella S, Devaux Y, Magni P, et al
   Biological Sex and Cardiovascular Disease Prevention in Systemic Arterial Hypertension.
   Arterioscler Thromb Vasc Biol. 2025 Sep 11. doi: 10.1161/ATVBAHA.125.322092.
   PubMed     Abstract available
   
   
   
6. SANTINELLI-PESTANA DV, Delwarde C, Kasai T, Kuraoka S, et al
   ADP-Ribosylation in Experimental Atherosclerosis: A Potential Link Between Dyslipidemia and Inflammation in Cardiovascular Disease.
   Arterioscler Thromb Vasc Biol. 2025 Sep 4. doi: 10.1161/ATVBAHA.125.322497.
   PubMed    
   
   
   
7. GARSHICK MS, Drenkova K, Kazatsker F, Boothman I, et al
   Platelet Activation and a Platelet Biosignature Are Associated With Cardiovascular Risk in Patients With Controlled Psoriasis.
   Arterioscler Thromb Vasc Biol. 2025 Sep 4. doi: 10.1161/ATVBAHA.125.322574.
   PubMed     Abstract available
   
   
   
8. QIU B, Cai X, Zhou L, Wang X, et al
   Association of Serum Thromboinflammatory Biomarkers With Atherosclerotic Plaques and Burden in a Community-Based Population.
   Arterioscler Thromb Vasc Biol. 2025;45:1672-1682.
   PubMed     Abstract available
   
   
   August 2025
9. YARMOLINSKY J, Lau E, Koskeridis F, Gunter MJ, et al
   Genome-Wide Pleiotropy Analysis Identifies Shared and Opposing Pathways Influencing Coronary Artery Disease and Cancer.
   Arterioscler Thromb Vasc Biol. 2025 Aug 28. doi: 10.1161/ATVBAHA.125.322433.
   PubMed     Abstract available
   
   
   
10. TSIMIKAS S, Kille A, Kaier K, Nuhrenberg T, et al
    Oxidized Phospholipids on Apo B(100), Platelet Activation and Reactivity, and Long-Term Cardiovascular Outcomes.
    Arterioscler Thromb Vasc Biol. 2025 Aug 14. doi: 10.1161/ATVBAHA.125.322347.
    PubMed     Abstract available
    
    
    
11. ZUBIRAN R, Sampson M, Wolska A, Remaley AT, et al
    Estimated Small, Dense LDL Cholesterol and Atherosclerotic Cardiovascular Risk in the UK Biobank.
    Arterioscler Thromb Vasc Biol. 2025 Aug 14. doi: 10.1161/ATVBAHA.125.323157.
    PubMed     Abstract available
    
    
    
12. AL ZAIDI M, Nickenig G
    Circular RNAs Complement Cardiovascular Messaging Machinery.
    Arterioscler Thromb Vasc Biol. 2025 Aug 7. doi: 10.1161/ATVBAHA.125.323371.
    PubMed    
    
    
    July 2025
13. ANDERSEN T, Ueland T, Ghukasyan Lakic T, Akerblom A, et al
    Correction to: C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes.
    Arterioscler Thromb Vasc Biol. 2025;45:e336.
    PubMed    
    
    
    June 2025
14. HLUSHCHENKO I, Pamilo S, Islam MM, Lahdeniemi IAK, et al
    Linking Variability of Leukocyte Lipid Metabolism to Circulating Lipids, Lipoprotein Composition, and Cardiovascular Risk in the Finnish Adult Population.
    Arterioscler Thromb Vasc Biol. 2025 Jun 19. doi: 10.1161/ATVBAHA.125.322801.
    PubMed     Abstract available
    
    
    
15. RICCIOTTI E, FitzGerald GA
    Prostaglandins and the Cardiovascular System.
    Arterioscler Thromb Vasc Biol. 2025;45:841-844.
    PubMed    
    
    
    May 2025
16. NAGESWARAN V, Carreras A, Reinshagen L, Beck KR, et al
    Gut Microbial Metabolite Imidazole Propionate Impairs Endothelial Cell Function and Promotes the Development of Atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2025;45:823-839.
    PubMed     Abstract available
    
    
    
17. BALINT L, Patel S, Serafin DS, Zhang H, et al
    Lymphatic Activation of ACKR3 Signaling Regulates Lymphatic Response After Ischemic Heart Injury.
    Arterioscler Thromb Vasc Biol. 2025;45:754-768.
    PubMed     Abstract available
    
    
    
18. MINUZ P, Giorgetti A, Meneguzzi A, Taus F, et al
    Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study.
    Arterioscler Thromb Vasc Biol. 2025;45:792-804.
    PubMed     Abstract available
    
    
    April 2025
19. JEON Y, Kwon Y, Kim YJ, Jeon S, et al
    Epigenetic Modulation of Vascular Smooth Muscle Cell Phenotype Switching in Early-Onset Acute Myocardial Infarction.
    Arterioscler Thromb Vasc Biol. 2025 Apr 17. doi: 10.1161/ATVBAHA.125.322503.
    PubMed     Abstract available
    
    
    
20. SANGHVI MM, Young WJ, Naderi H, Burns R, et al
    Using Genomics to Develop Personalized Cardiovascular Treatments.
    Arterioscler Thromb Vasc Biol. 2025 Apr 17. doi: 10.1161/ATVBAHA.125.319221.
    PubMed     Abstract available
    
    
    March 2025
21. SALIDO E, de Medeiros Vieira C, Mosquera JV, Zade R, et al
    9p21.3 Coronary Artery Disease Risk Locus Drives Vascular Smooth Muscle Cells to an Osteochondrogenic State.
    Arterioscler Thromb Vasc Biol. 2025 Mar 27. doi: 10.1161/ATVBAHA.124.322045.
    PubMed     Abstract available
    
    
    
22. STADLER JT, Borenich A, Stattau Bisgaard L, Bjergfelt SS, et al
    ApoM and Major Adverse Cardiovascular Events in Chronic Kidney Disease: A Prospective Cohort Study.
    Arterioscler Thromb Vasc Biol. 2025 Mar 6. doi: 10.1161/ATVBAHA.124.322367.
    PubMed     Abstract available
    
    
    
23. LEANDER K, Chen YQ, Vikstrom M, Silveira A, et al
    Circulating ANGPTL3/8 Concentrations Are Associated With an Atherogenic Lipoprotein Profile and Increased CHD Risk in Swedish Population-Based Studies.
    Arterioscler Thromb Vasc Biol. 2025;45:443-451.
    PubMed     Abstract available
    
    
    
24. 
    Correction to: Effect of Vectors on Human Endothelial Cell Signal Transduction: Implications for Cardiovascular Gene Therapy.
    Arterioscler Thromb Vasc Biol. 2025;45:e99.
    PubMed    
    
    
    
25. 
    Correction to: Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks-Brief Report.
    Arterioscler Thromb Vasc Biol. 2025;45:e100.
    PubMed    
    
    
    January 2025
26. NEWMAN AAC, Dalman JM, Moore KJ
    Cardiovascular Disease and Cancer: A Dangerous Liaison.
    Arterioscler Thromb Vasc Biol. 2025 Jan 9. doi: 10.1161/ATVBAHA.124.319863.
    PubMed     Abstract available
    
    
    December 2024
27. STONE CR, Harris DD, Broadwin M, Kanuparthy M, et al
    Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2024 Dec 12. doi: 10.1161/ATVBAHA.124.321850.
    PubMed     Abstract available
    
    
    
28. JI H, Sabanayagam C, Matsushita K, Cheng CY, et al
    Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks.
    Arterioscler Thromb Vasc Biol. 2024 Dec 12. doi: 10.1161/ATVBAHA.124.321629.
    PubMed     Abstract available
    
    
    
29. LIOU L, Garcia-Gonzalez J, Wu HM, Wang Z, et al
    Clinical and Genomic Prediction of Coronary Artery Disease Subtypes.
    Arterioscler Thromb Vasc Biol. 2024 Dec 5. doi: 10.1161/ATVBAHA.124.321846.
    PubMed     Abstract available
    
    
    
30. VAN ECK M
    SR-BI Models for Spontaneous Myocardial Infarction: High Unesterified/Total Cholesterol Ratio Not the Sole Piece of the Puzzle.
    Arterioscler Thromb Vasc Biol. 2024;44:2489-2492.
    PubMed    
    
    
    
31. GAO XF, Chen AQ, Tang HY, Kong XQ, et al
    m(6)A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway.
    Arterioscler Thromb Vasc Biol. 2024;44:2543-2559.
    PubMed     Abstract available
    
    
    
32. BAATEN CCFMJ, Nagy M, Spronk HMH, Ten Cate H, et al
    NETosis in Cardiovascular Disease: An Opportunity for Personalized Antithrombotic Treatments?
    Arterioscler Thromb Vasc Biol. 2024;44:2366-2370.
    PubMed    
    
    
    November 2024
33. KHRAISHAH H, Ostergard RL Jr, Nabi SR, De Alwis D, et al
    Climate Change and Cardiovascular Disease: Who Is Vulnerable?
    Arterioscler Thromb Vasc Biol. 2024 Nov 26. doi: 10.1161/ATVBAHA.124.318681.
    PubMed     Abstract available
    
    
    
34. BONDONNO NP, Parmenter BH, Murray K, Bondonno CP, et al
    Associations Between Flavonoid Intake and Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis.
    Arterioscler Thromb Vasc Biol. 2024;44:2347-2359.
    PubMed     Abstract available
    
    
    October 2024
35. ONNIS C, Virmani R, Madra A, Nardi V, et al
    Whys and Wherefores of Coronary Arterial Positive Remodeling.
    Arterioscler Thromb Vasc Biol. 2024 Oct 31. doi: 10.1161/ATVBAHA.124.321504.
    PubMed     Abstract available
    
    
    
36. WILKINSON MJ, Shapiro MD
    Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay.
    Arterioscler Thromb Vasc Biol. 2024 Oct 31. doi: 10.1161/ATVBAHA.124.319983.
    PubMed     Abstract available
    
    
    
37. ELIAS-LOPEZ D, Vedel-Krogh S, Kobylecki CJ, Wadstrom BN, et al
    Impaired Renal Function With Higher Remnant Cholesterol Related to Risk of Atherosclerotic Cardiovascular Disease: CGPS.
    Arterioscler Thromb Vasc Biol. 2024 Oct 24. doi: 10.1161/ATVBAHA.124.321387.
    PubMed     Abstract available
    
    
    
38. SU S, Chen Z, Ke Q, Kocher O, et al
    Nanoparticle-Directed Antioxidant Therapy Can Ameliorate Disease Progression in a Novel, Diet-Inducible Model of Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2024 Oct 17. doi: 10.1161/ATVBAHA.124.321030.
    PubMed     Abstract available
    
    
    
39. POTERE N, Bonaventura A, Abbate A
    Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases.
    Arterioscler Thromb Vasc Biol. 2024 Oct 10. doi: 10.1161/ATVBAHA.124.319980.
    PubMed     Abstract available
    
    
    
40. HILSER JR, Spencer NJ, Afshari K, Gilliland FD, et al
    COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type.
    Arterioscler Thromb Vasc Biol. 2024 Oct 9. doi: 10.1161/ATVBAHA.124.321001.
    PubMed     Abstract available
    
    
    September 2024
41. GASTANADUI MG, Margaroli C, Litovsky S, Richter RP, et al
    Spatial Transcriptomic Approach to Understanding Coronary Atherosclerotic Plaque Stability.
    Arterioscler Thromb Vasc Biol. 2024 Sep 5. doi: 10.1161/ATVBAHA.123.320330.
    PubMed     Abstract available
    
    
    August 2024
42. TRAVERS RJ, Stepanian A, Jaffe I
    Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors.
    Arterioscler Thromb Vasc Biol. 2024 Aug 15. doi: 10.1161/ATVBAHA.124.319864.
    PubMed     Abstract available
    
    
    
43. DEROISSART J, Binder CJ, Porsch F
    Role of Antibodies and Their Specificities in Atherosclerotic Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2024 Aug 8. doi: 10.1161/ATVBAHA.124.319843.
    PubMed     Abstract available
    
    
    
44. WU H, Wei J, Chen W, Chen L, et al
    Leisure Sedentary Behavior, Physical Activities, and Cardiovascular Disease Among Individuals With Metabolic Dysfunction-Associated Fatty Liver Disease.
    Arterioscler Thromb Vasc Biol. 2024 Aug 1. doi: 10.1161/ATVBAHA.124.321214.
    PubMed     Abstract available
    
    
    
45. PROTTY MB, Tyrrell VJ, Allen-Redpath K, Soyama S, et al
    Thrombin Generation Is Associated With Extracellular Vesicle and Leukocyte Lipid Membranes in Atherosclerotic Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2024 Aug 1. doi: 10.1161/ATVBAHA.124.320902.
    PubMed     Abstract available
    
    
    July 2024
46. LEE J, Gilliland T, Dron J, Koyama S, et al
    Integrative Metabolomics Differentiate Coronary Artery Disease, Peripheral Artery Disease, and Venous Thromboembolism Risks.
    Arterioscler Thromb Vasc Biol. 2024 Jul 25. doi: 10.1161/ATVBAHA.124.321282.
    PubMed     Abstract available
    
    
    
47. GUNASENA M, Alles M, Wijewantha Y, Mulhern W, et al
    Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19.
    Arterioscler Thromb Vasc Biol. 2024 Jul 11. doi: 10.1161/ATVBAHA.124.321085.
    PubMed     Abstract available
    
    
    
48. ZHANG H, Kafeiti N, Masarik K, Lee S, et al
    Decoding Endothelial MPL and JAK2V617F Mutation: Insight Into Cardiovascular Dysfunction in Myeloproliferative Neoplasms.
    Arterioscler Thromb Vasc Biol. 2024 Jul 11. doi: 10.1161/ATVBAHA.124.321008.
    PubMed     Abstract available
    
    
    
49. LIU X, Yuan M, Zhao D, Zeng Q, et al
    Single-Nucleus Transcriptomic Atlas of Human Pericoronary Epicardial Adipose Tissue in Normal and Pathological Conditions.
    Arterioscler Thromb Vasc Biol. 2024;44:1628-1645.
    PubMed     Abstract available
    
    
    
50. 
    Correction to: Colchicine's Role in Cardiovascular Disease Management.
    Arterioscler Thromb Vasc Biol. 2024;44:e208.
    PubMed    
    
    
    
51. WANG X, Liu L, Zhai L, Palade P, et al
    Direct Impact of PCSK9 on SMC Senescence and Apoptosis: A New Focus in Cardiovascular Diseases.
    Arterioscler Thromb Vasc Biol. 2024;44:1491-1496.
    PubMed    
    
    
    
52. ZHAO C, Lv R, Maehara A, Wang L, et al
    Plaque Ruptures Are Related to High Plaque Stress and Strain Conditions: Direct Verification by Using In Vivo OCT Rupture Data and FSI Models.
    Arterioscler Thromb Vasc Biol. 2024;44:1617-1627.
    PubMed     Abstract available
    
    
    June 2024
53. MENCKE R, Al Ali L, de Koning MLY, Pasch A, et al
    Serum Calcification Propensity Is Increased in Myocardial Infarction and Hints at a Pathophysiological Role Independent of Classical Cardiovascular Risk Factors.
    Arterioscler Thromb Vasc Biol. 2024 Jun 20. doi: 10.1161/ATVBAHA.124.320974.
    PubMed     Abstract available
    
    
    May 2024
54. O'BRIEN JW, Case A, Kemper C, Zhao TX, et al
    Therapeutic Avenues to Modulate B-Cell Function in Patients With Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2024 May 30. doi: 10.1161/ATVBAHA.124.319844.
    PubMed     Abstract available
    
    
    
55. TRINDER M, Cermakova L, Ruel I, Baass A, et al
    Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2024 May 23. doi: 10.1161/ATVBAHA.123.320287.
    PubMed     Abstract available
    
    
    
56. BELIARD S, Saheb S, Litzler-Renault S, Vimont A, et al
    Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia.
    Arterioscler Thromb Vasc Biol. 2024 May 2. doi: 10.1161/ATVBAHA.123.320609.
    PubMed     Abstract available
    
    
    
57. WADSTROM BN, Pedersen KM, Wulff AB, Nordestgaard BG, et al
    Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study.
    Arterioscler Thromb Vasc Biol. 2024;44:1144-1155.
    PubMed     Abstract available
    
    
    April 2024
58. GHOUSE J, Ahlberg G, Rand SA, Olesen MS, et al
    Potential Influence of Risk Factor Control on the Association Between Lipoprotein(a) and Atherosclerotic Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2024 Apr 25. doi: 10.1161/ATVBAHA.124.320990.
    PubMed    
    
    
    
59. SOUCY A, Potts C, Kaija A, Harrington A, et al
    Effects of a Global Rab27a Null Mutation on Murine PVAT and Cardiovascular Function.
    Arterioscler Thromb Vasc Biol. 2024 Apr 25. doi: 10.1161/ATVBAHA.124.320969.
    PubMed     Abstract available
    
    
    
60. SELVARAJAN I, Kiema M, Huang RT, Li J, et al
    Coronary Artery Disease Risk Variant Dampens the Expression of CALCRL by Reducing HSF Binding to Shear Stress Responsive Enhancer in Endothelial Cells In Vitro.
    Arterioscler Thromb Vasc Biol. 2024 Apr 11. doi: 10.1161/ATVBAHA.123.318964.
    PubMed     Abstract available
    
    
    
61. TAKEDA S, Emoto T, Yamashita T, Yamamoto H, et al
    Single-Cell RNA Sequencing Reveals an Immune Landscape of CD4(+) T Cells in Coronary Culprit Plaques With Acute Coronary Syndrome in Humans.
    Arterioscler Thromb Vasc Biol. 2024 Apr 4. doi: 10.1161/ATVBAHA.123.320409.
    PubMed     Abstract available
    
    
    
62. DAUGHERTY A, Sawada H, Sheppard MB, Lu HS, et al
    Angiotensinogen as a Therapeutic Target for Cardiovascular and Metabolic Diseases.
    Arterioscler Thromb Vasc Biol. 2024 Apr 4. doi: 10.1161/ATVBAHA.124.318374.
    PubMed     Abstract available
    
    
    March 2024
63. BUCKLEY LF, Libby P
    Role of Colchicine in Cardiovascular Disease Management.
    Arterioscler Thromb Vasc Biol. 2024 Mar 21. doi: 10.1161/ATVBAHA.124.319851.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.